[Breaking] Juul’s Device and 4 Pod Products Officially Authorized by FDA, Reenters the U.S. Regulated Market

Jul.17
[Breaking] Juul’s Device and 4 Pod Products Officially Authorized by FDA, Reenters the U.S. Regulated Market
After a one-year hiatus, the FDA has once again authorized new e-cigarette products—approving one device and four pod products from Juul, marking its return to the regulated market.

Reporter | 2Firsts

 

According to the latest update of the FDA’s List of Authorized E-Cigarette Products (July 2025), Juul Labs Inc. has officially received Marketing Granted Orders (MGOs) for five of its products, including:

 

· JUUL Device

· JUULpods [Menthol 3.0%]

· JUULpods [Menthol 5.0%]

· JUULpods [Virginia Tobacco 3.0%]

· JUULpods [Virginia Tobacco 5.0%]

 

【重磅快讯】JUUL 1款烟具及4款烟弹正式获FDA授权,重返合规市场

 

This marks Juul’s return to the FDA’s list of authorized e-cigarette products, three years after the agency issued a market ban in 2022. The approved products include Juul’s core menthol and Virginia tobacco flavored pods.

 

To date, the FDA has granted authorization to e-cigarette products from four manufacturers: Logic, NJOY, Reynolds (Vuse), and now Juul. The total number of authorized products has increased from 34 to 39.

 

In July 2024, RJ Reynolds Vapor Company, a subsidiary of British American Tobacco, secured FDA authorization for seven Vuse Alto products. Juul’s approval represents the first new MGO issued in over a year, signaling a potentially significant shift in the U.S. e-cigarette regulatory landscape.

 

2Firsts will continue to monitor Juul’s market reentry and its broader impact on the industry.

 

KT&G Collaborates with Beauty Brand Hotel Dawson to Launch Limited Edition Heated Tobacco “Lil Hybrid 3.0”
KT&G Collaborates with Beauty Brand Hotel Dawson to Launch Limited Edition Heated Tobacco “Lil Hybrid 3.0”
KT&G has partnered with South Korean beauty and lifestyle brand Hotel Dawson to jointly launch the heated tobacco product “Lil Hybrid 3.0,” which will be available across multiple sales platforms.
Jul.21 by 2FIRSTS.ai
Retraction Statement Regarding the Article: “2Firsts Investigation | U.S. Tightens E-Cigarette Enforcement, Disrupting China Air Shipments — Industry Estimates $78 Million in Goods Seized in Six Months”
Retraction Statement Regarding the Article: “2Firsts Investigation | U.S. Tightens E-Cigarette Enforcement, Disrupting China Air Shipments — Industry Estimates $78 Million in Goods Seized in Six Months”
Retraction Statement.
Jul.15
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
UK Releases Latest Approved E-cigarette List: 227 New SKUs Cleared, Including ELFBAR, LOST MARY, and VAPORESSO
UK Releases Latest Approved E-cigarette List: 227 New SKUs Cleared, Including ELFBAR, LOST MARY, and VAPORESSO
Between July 19 and 28, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published 227 SKUs in its e-cigarette product notification database, including updates on high-puff devices, refillable pods, and multi-flavor cartridges from brands such as ELFBAR, LOST MARY, and VAPORESSO.
Jul.28 by 2FIRSTS.ai
U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
On July 23, 2025, the U.S. Court of Appeals for the Fifth Circuit ruled to reject the petition for judicial review filed by Shenzhen IVPS Technology Co., Ltd. (IVPS) and its U.S. distributor ECIGRUSA (Worldwide Vape Distribution) against the FDA, thereby upholding the FDA’s denial of their Premarket Tobacco Product Applications (PMTAs) for six open-system e-cigarette devices and components. The court held that the lack of key evidence on “abuse liability” alone was sufficient grounds to support
Aug.15 by 2FIRSTS.ai
2FIRSTS成为InterTabac官方媒体合作伙伴,提供定制品牌传播资源。
2FIRSTS成为InterTabac官方媒体合作伙伴,提供定制品牌传播资源。
2FIRSTS reestablished as official media partner for InterTabac 2025, offering tailored global brand exposure packages for tobacco industry exhibitors.
Aug.06 by 2FIRSTS.ai